BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21553281)

  • 1. Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients.
    El Agouza IM; Eissa SS; El Houseini MM; El-Nashar DE; Abd El Hameed OM
    Angiogenesis; 2011 Sep; 14(3):321-30. PubMed ID: 21553281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.
    Iovino F; Ferraraccio F; Orditura M; Antoniol G; Morgillo F; Cascone T; Diadema MR; Aurilio G; Santabarbara G; Ruggiero R; Belli C; Irlandese E; Fasano M; Ciardiello F; Procaccini E; Lo Schiavo F; Catalano G; De Vita F
    Cancer Invest; 2008; 26(3):250-5. PubMed ID: 18317965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor.
    El Tarhouny S; Seefeld M; Fan AX; Hahn S; Holzgreve W; Zhong XY
    Cytokine; 2008 Oct; 44(1):65-9. PubMed ID: 18691902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between serum VEGF level and VEGF, COX-2 and MVD expression in breast cancer tissues].
    Li EX; Wu YY; Shi F; Wu Y; Guo JJ; Dong DF
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):522-5. PubMed ID: 18069633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
    Adams J; Carder PJ; Downey S; Forbes MA; MacLennan K; Allgar V; Kaufman S; Hallam S; Bicknell R; Walker JJ; Cairnduff F; Selby PJ; Perren TJ; Lansdown M; Banks RE
    Cancer Res; 2000 Jun; 60(11):2898-905. PubMed ID: 10850435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.
    Findeisen R; Albrecht S; Richter B; Deutschmann K; Zimmermann T; Distler W
    Luminescence; 2000; 15(5):283-9. PubMed ID: 11038485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.
    Lantzsch T; Hefler L; Krause U; Kehl A; Goepel C; Koelbl H; Dunst J; Lampe D
    Anticancer Res; 2002; 22(3):1925-8. PubMed ID: 12168895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer.
    Su MY; Cheung YC; Fruehauf JP; Yu H; Nalcioglu O; Mechetner E; Kyshtoobayeva A; Chen SC; Hsueh S; McLaren CE; Wan YL
    J Magn Reson Imaging; 2003 Oct; 18(4):467-77. PubMed ID: 14508784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of serum vascular endothelial growth factor as an angiogenesis biomarker with nitric oxide & urokinase-type plasminogen activator in breast cancer patients.
    Konukoglu D; Turhan MS; Celik V; Turna H
    Indian J Med Res; 2007 Jun; 125(6):747-51. PubMed ID: 17704550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
    Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
    Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of some trace elements concentration in blood, tumor free breast and tumor tissues of women with benign and malignant breast lesions: an Indian study.
    Siddiqui MK; Jyoti ; Singh S; Mehrotra PK; Singh K; Sarangi R
    Environ Int; 2006 Jul; 32(5):630-7. PubMed ID: 16580070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over expression of vascular endothelial growth factor in correlation to Ki-67, grade, and stage of breast cancer.
    Al-Harris ES; Al-Janabi AA; Al-Toriahi KM; Yasseen AA
    Saudi Med J; 2008 Aug; 29(8):1099-104. PubMed ID: 18690299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic MRI and tumor angiogenesis of breast cancer].
    Yasumura K; Ogawa K; Yuasa Y; Hiramatsu H; Hiramatsu K; Kitajima M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Jun; 60(7):379-88. PubMed ID: 10921297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relevance of tumor angiogenesis in occurrence and development of breast cancer].
    Liu Y; Wang G; Xu WG; Song JN; Yang XQ; Wang WY
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1687-9. PubMed ID: 19957527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
    Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
    BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.